Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calogero Saieva

Showing results (141-150 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|September 11, 2019
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue SarcomaDaniela Greto, Calogero Saieva, Mauro Loi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence TrialIcro Meattini, Livia Marrazzo, Calogero Saieva, et al.
Cancers|December 3, 2020
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire DevelopmentPierluigi Bonomo, Alice Maruelli, Calogero Saieva, et al.
Journal of Translational Medicine|February 4, 2023
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancerPier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
Clinical outcomes of volume of disease on patients receiving enzalutamide <i>versus</i> abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancerPier Vitale Nuzzo, Francesco Ravera, Calogero Saieva, et al.
Mutagenesis|September 7, 2010
Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancerDomenico Palli, Silvia Polidoro, Mariarosaria D'Errico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 5, 2018
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)Icro Meattini, Nadia Pasinetti, Bruno Meduri, et al.
La Radiologia Medica|October 22, 2024
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trialLivia Marrazzo, Icro Meattini, Carlotta Becherini, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
JAMA Oncology|August 26, 2021
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical TrialLorenzo Livi, Giuseppe Barletta, Francesca Martella, et al.
Pageof 20

Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|September 11, 2019
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue SarcomaDaniela Greto, Calogero Saieva, Mauro Loi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence TrialIcro Meattini, Livia Marrazzo, Calogero Saieva, et al.
Cancers|December 3, 2020
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire DevelopmentPierluigi Bonomo, Alice Maruelli, Calogero Saieva, et al.
Journal of Translational Medicine|February 4, 2023
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancerPier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
Clinical outcomes of volume of disease on patients receiving enzalutamide <i>versus</i> abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancerPier Vitale Nuzzo, Francesco Ravera, Calogero Saieva, et al.
Mutagenesis|September 7, 2010
Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancerDomenico Palli, Silvia Polidoro, Mariarosaria D'Errico, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 5, 2018
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study)Icro Meattini, Nadia Pasinetti, Bruno Meduri, et al.
La Radiologia Medica|October 22, 2024
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trialLivia Marrazzo, Icro Meattini, Carlotta Becherini, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
JAMA Oncology|August 26, 2021
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical TrialLorenzo Livi, Giuseppe Barletta, Francesca Martella, et al.
Pageof 20